Thrive Capital Management (Pennsylvania)’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-6,905
| Closed | -$296K | – | 194 |
|
|
2024
Q1 | $296K | Buy |
6,905
+400
| +6% | +$17.1K | 0.16% | 81 |
|
|
2023
Q4 | $241K | Buy |
+6,505
| New | +$241K | 0.13% | 125 |
|
|
2021
Q2 | – | Sell |
-20,618
| Closed | -$920K | – | 112 |
|
|
2021
Q1 | $920K | Buy |
20,618
+10,371
| +101% | +$463K | 0.86% | 33 |
|
|
2020
Q4 | $471K | Buy |
+10,247
| New | +$471K | 0.5% | 47 |
|